Blog Large Image Simple

New summer menus available from 12th Sept.

JangoBio is seeing positive results from ongoing animal testing for a therapy that could be used to treat aging-related diseases. The therapy in question relies on stem cells to regrow key tissues that play a key role in balancing hormones. These tissues naturally degrade as the...

Daily Nonstop Service Begins with A Departure Gate Celebration Madison, WI – The Bay Area is now a non-stop flight away for business and leisure travelers throughout Dane County and south central Wisconsin thanks to United Airlines’ launch of daily non-stop, year-round service to San Francisco...

Before co-working spaces there were coffee shops. Popular among college students, freelancers and other members of the gig economy escaping the isolation and distraction of working from home, these “third spaces” were — and still are — great places to throw on your headphones and get some work done....

BioForward and Wisconsin Economic Development Corporation partner to provide local biohealth companies the opportunity to represent Wisconsin at international BIO conference. Thirty scholarships have been awarded to Wisconsin biohealth companies to attend and exhibit at the International BIO Convention in Boston, MA, June 4-7, 2018. Recipients...

A new building going up at UW Health’s clinical and research complex on Madison’s West Side will be home to an expanded focus on two hot fields: genetic testing and treatments tailored to the genetic makeup of patients or their disease. The newly created UW Center...

Protecting production crops against bacterial invasion is an eternal struggle for agriculture. Antibiotics can’t address everything that poses a threat, and many pathogens have evolved to become resistant to antibiotics. Novel ways to address bacterial pathogens must be developed to keep crops safe and available for...

Invenra, a URP tenant / biotech startup that develops therapeutic antibodies for pharma companies, is joining forces with a Bay Area company to discover and develop new treatments for cancer. Under the agreement, Exelixis will pay Invenra $2 million upfront, plus an additional $2 million at...